Share price settled down, expect good newsflow over coming months with a big move north, small free float, plenty of cash raised, sales commencing in USA and rest of world, also IB receiving grant funding for 5 years, $2.75 million dollars I think without checking RNS, massive potential,finally Trevor Brown 30% shareholder and no spring chicken, sorry Trevor! will be looking for a big exit sale next 12 months.
It’s exciting times for iqai shareholders but let’s not get to excited just yet from years of experience witnessing huge jumps like Fridays there is usually a slight pullback however I do feel an fda approval is a special event for any healthcare stock so hopefully we will power on through the sellers.
IB StoneChecker® analysis software is in the final stages of FDA clearance for distribution in the US and will also be added to the CorTechs' portfolio, internationally. StoneChecker provides a critical tool in the management of kidney stone treatment. The software analyses 32 different standardised parameters to distinguish kidney stone size, location and composition to provide conclusive data that determines if lithotripsy is an effective treatment option.
people will sell after results, which was fine but 3 months since FDA approval was imminent people will sell and play elsewhere, so agree could get choppy until FDA approval arrives but hold to many to trade!
Good read! IAQI, very low expenditure to 30/6/19 and small loss, next 12 months very exciting, FDA approval soon! hopefully DS will do another proactive interview, think quite a bit more news will come before Xmas.
We will have news this month about FDA approval, interim's have to be released this month, painful that it has taken so long from the 12/6 but excellent news last week which has not been appreciated by market.
Correct main listing, delayed buy maybe, news got to be close, just FDA approval put to bed and then company can move forward in USA and start to create sales, think next 6-12 months could see real share price appreciation if the get right news, low shares in circulation and low free float.
RE: Additional Grant Award - $2.75 mill04 Sep 2019 14:34
IB is a private american company and I do not think today's news will attract buyers from USA to buy IQAI shares. What I think it will do is raise the profile of IB which will attract buyers of the company , grant of that size completely validates the tech.